Active ingredientIpriflavoneCat. No. P-I071-001CAS 35212-22-7Family · Pharmaceutical analytical standards
Ipriflavone
A synthetic isoflavone born from a research project started in 1969 and later studied in humans: it has been used in Italy and Japan to prevent loss of bone mass after menopause. This family brings together the active ingredient and other impurities.
Did you know?The project aimed to obtain, from soy isoflavones, a molecule that would protect bone without oestrogenic effects: indeed ipriflavone, although an isoflavone, does not bind to oestrogen receptors.
Go to the active ingredient →Active ingredientIpriflavoneCat. No. P-I071-001CAS 35212-22-7
Impurity7,8-DihydroxyflavoneCat. No. P-I071-002CAS 38183-03-8
Impurity7-Ethoxy-3-phenyl-4H-chromen-4-oneCat. No. P-I071-003CAS 13057-73-3
Impurity7-HydroxyisoflavoneCat. No. P-I071-004CAS 13057-72-2
ImpurityIpriflavone Impurity 1Cat. No. P-I071-005CAS 50561-04-1
ImpurityIpriflavone Impurity 2Cat. No. P-I071-006CAS 2137978-60-8
ImpurityIpriflavone Impurity 3Cat. No. P-I071-007
ImpurityIpriflavone Impurity 4Cat. No. P-I071-008No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.